ACM Research Zukünftiges Wachstum
Future Kriterienprüfungen 3/6
ACM Research wird ein jährliches Gewinn- und Umsatzwachstum von 15.7% bzw. 16.7% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 14.6% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 16.2% betragen.
Wichtige Informationen
15.6%
Wachstumsrate der Gewinne
14.6%
EPS-Wachstumsrate
| Semiconductor Gewinnwachstum | 24.5% |
| Wachstumsrate der Einnahmen | 16.8% |
| Zukünftige Eigenkapitalrendite | 16.2% |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 12 Jun 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
ACM Research: Niche Deep Value In The Semiconductor Space
Jun 12Is It Too Late To Consider Buying ACM Research, Inc. (NASDAQ:ACMR)?
Jun 05
Does ACM Research (NASDAQ:ACMR) Deserve A Spot On Your Watchlist?
May 23ACM Research: The Road To $1B Revenue
May 11ACM Research (NASDAQ:ACMR) Has A Pretty Healthy Balance Sheet
Apr 11ACM Research: Undervalued In Light Of Expected Growth Years
Mar 29ACM Research Sees Strong Growth But May Face International Headwinds
Mar 04What ACM Research, Inc.'s (NASDAQ:ACMR) 63% Share Price Gain Is Not Telling You
Feb 29At US$19.58, Is It Time To Put ACM Research, Inc. (NASDAQ:ACMR) On Your Watch List?
Feb 20Here's What's Concerning About ACM Research's (NASDAQ:ACMR) Returns On Capital
Feb 05Here's Why We Think ACM Research (NASDAQ:ACMR) Is Well Worth Watching
Jan 22ACM Research: Remains A Buy
Jan 15ACM Research (NASDAQ:ACMR) Has A Pretty Healthy Balance Sheet
Jan 09Pinning Down ACM Research, Inc.'s (NASDAQ:ACMR) P/E Is Difficult Right Now
Dec 27Is Now An Opportune Moment To Examine ACM Research, Inc. (NASDAQ:ACMR)?
Nov 10There's Been No Shortage Of Growth Recently For ACM Research's (NASDAQ:ACMR) Returns On Capital
Oct 12Here's Why ACM Research (NASDAQ:ACMR) Can Manage Its Debt Responsibly
Sep 29If EPS Growth Is Important To You, ACM Research (NASDAQ:ACMR) Presents An Opportunity
Sep 13Is Now The Time To Look At Buying ACM Research, Inc. (NASDAQ:ACMR)?
Jun 28Is ACM Research (NASDAQ:ACMR) A Risky Investment?
Jun 12Returns On Capital Are Showing Encouraging Signs At ACM Research (NASDAQ:ACMR)
May 27Why ACM Research, Inc. (NASDAQ:ACMR) Could Be Worth Watching
Mar 23Does ACM Research (NASDAQ:ACMR) Have A Healthy Balance Sheet?
Mar 02Returns On Capital Are Showing Encouraging Signs At ACM Research (NASDAQ:ACMR)
Feb 15If EPS Growth Is Important To You, ACM Research (NASDAQ:ACMR) Presents An Opportunity
Dec 06ACM Research Shanghai sees Q3 revenue RMB 850M-RMB 930M
Oct 13ACM Research (NASDAQ:ACMR) Might Be Having Difficulty Using Its Capital Effectively
Oct 11Here's Why ACM Research (NASDAQ:ACMR) Can Manage Its Debt Responsibly
Sep 19ACM Research, Inc. (NASDAQ:ACMR) Shares Could Be 49% Below Their Intrinsic Value Estimate
Aug 30ACM Research Is Still Facing Unresolved Issues
Aug 15ACM Research Q2 2022 Earnings Preview
Aug 04Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2026 | 1,111 | 146 | 75 | 188 | 3 |
| 12/31/2025 | 870 | 112 | -45 | 30 | 7 |
| 12/31/2024 | 703 | 84 | 112 | 212 | 7 |
| 3/31/2024 | 636 | 88 | -130 | -54 | N/A |
| 12/31/2023 | 558 | 77 | -140 | -75 | N/A |
| 9/30/2023 | 496 | 71 | -165 | -43 | N/A |
| 6/30/2023 | 461 | 67 | -135 | -25 | N/A |
| 3/31/2023 | 421 | 52 | -169 | -65 | N/A |
| 12/31/2022 | 389 | 39 | -155 | -62 | N/A |
| 9/30/2022 | 375 | 43 | -124 | -98 | N/A |
| 6/30/2022 | 309 | 32 | -114 | -102 | N/A |
| 3/31/2022 | 258 | 27 | -90 | -79 | N/A |
| 12/31/2021 | 260 | 38 | -50 | -40 | N/A |
| 9/30/2021 | 210 | 31 | -50 | -9 | N/A |
| 6/30/2021 | 191 | 29 | -44 | -3 | N/A |
| 3/31/2021 | 176 | 23 | -64 | -7 | N/A |
| 12/31/2020 | 157 | 19 | -69 | -14 | N/A |
| 9/30/2020 | 136 | 14 | -14 | 6 | N/A |
| 6/30/2020 | 121 | 14 | -14 | 3 | N/A |
| 3/31/2020 | 111 | 19 | 15 | 16 | N/A |
| 12/31/2019 | 108 | 19 | 8 | 9 | N/A |
| 9/30/2019 | 104 | 17 | 4 | 5 | N/A |
| 6/30/2019 | 94 | 12 | 5 | 6 | N/A |
| 3/31/2019 | 85 | 11 | 9 | 11 | N/A |
| 12/31/2018 | 75 | 7 | 5 | 7 | N/A |
| 9/30/2018 | 71 | 8 | -9 | -6 | N/A |
| 6/30/2018 | 53 | 3 | -17 | -15 | N/A |
| 3/31/2018 | 41 | -1 | -17 | -16 | N/A |
| 12/31/2017 | 37 | 0 | N/A | -8 | N/A |
| 9/30/2017 | 34 | -3 | N/A | -11 | N/A |
| 6/30/2017 | 34 | -2 | N/A | -5 | N/A |
| 3/31/2017 | 29 | -1 | N/A | -6 | N/A |
| 12/31/2016 | 27 | 1 | N/A | -4 | N/A |
| 9/30/2016 | 30 | 3 | N/A | 4 | N/A |
| 12/31/2015 | 31 | 5 | N/A | 3 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: ACMRDas prognostizierte Gewinnwachstum (15.7% pro Jahr) liegt über der Sparquote (2.4%).
Ertrag vs. Markt: ACMRDie Erträge des Unternehmens (15.7% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (14.7% pro Jahr).
Hohe Wachstumserträge: ACMRDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.
Einnahmen vs. Markt: ACMRDie Einnahmen des Unternehmens (16.7% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (8.4% pro Jahr).
Hohe Wachstumseinnahmen: ACMRDie Einnahmen des Unternehmens (16.7% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: ACMRDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (16.2 %).